The calpain inhibitor MDL28170 induces the expression of apoptotic markers in leishmania amazonensis promastigotes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Marinho, Fernanda A ^a   Gonçalves, Keyla C S ^b   Oliveira, Simone S C ^a   Gonçalves, Diego S ^a   Matteoli, Filipe P ^a   Seabra, Sergio H ^c   Oliveira, Ana Carolina S ^a   Bellio, Maria ^a   Oliveira, Selma S ^a   Souto Padrón, Thaïs ^a   D'Avila Levy, Claudia M ^b   Santos, André L S ^a   Branquinha, Marta H ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Centro Universitario Estadual da Zona Oeste UEZO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

APOPTOSIS; ARTICLE; CELL AGGREGATION; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; IC 50; LEISHMANIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PARASITE VIABILITY; PROMASTIGOTE; PROTEIN BINDING;

APOPTOSIS; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; DNA FRAGMENTATION; DNA, PROTOZOAN; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTOZOAN PROTEINS;

EID: 84900336254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087659     Document Type: Article

References (56)

1. World Health Organization. (2013) Leishmaniasis. Available: http://www.who.int./leishmaniasis/en/. Accessed 17 May 2013.
2. Lainson R, Ryan L, Shaw JJ (1987) Infective stages of Leishmania in the sandfly vector and some observations on the mechanism of transmission. Mem Inst Oswaldo Cruz 82: 421-424.
3. Grimaldi G Jr, Tesh RB (1993) Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 6: 230-250.
4. den Boer M, Argaw D, Jannin J, Alvar J (2011) Leishmaniasis impact and treatment access. Clin Microbiol Infect 17: 1471-1477.
5. Polonio T, Efferth T (2008) Leishmaniasis: drug resistance and natural products (review). Int J Mol Med 22: 277-286.
6. Goto H, Lindoso JA (2010) Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 8: 419-433.
7. d'Avila-Levy CM, Marinho FA, Santos LO, Martins JL, Santos AL, et al. (2006) Antileishmanial activity of MDL 28170, a potent calpain inhibitor. Int J Antimicrob Agents 28: 138-142. (Pubitemid 44164364)
8. Mehdi S (1991) Cell-penetrating inhibitors of calpain. Trends Biochem Sci 16: 150-153.
9. Carragher NO (2006) Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des 12: 615-638.
10. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83: 731-801. (Pubitemid 36828925)
11. Sorimachi H, Hata S, Ono Y (2011) Impact of genetic insights into calpain biology. J Biochem 150: 23-37.
12. Croall DE, Ersfeld K (2007) The calpains: modular designs and functional diversity. Genome Biol 8: 218.
13. Ono Y, Sorimachi H (2012) Calpains - an elaborate proteolytic system. Biochim Biophys Acta 1824: 224-236.
14. Sangenito LS, Ennes-Vidal V, Marinho FA, Da Mota FF, Santos AL, et al. (2009) Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms. Parasitology 136: 433-441.
15. Ennes-Vidal V, Menna-Barreto RF, Santos AL Branquinha MH, d'Avila-Levy CM (2010) Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro. J Antimicrob Chemother 65: 1395-1398.
16. Ennes-Vidal V, Menna-Barreto RF, Santos AL Branquinha MH, d'Avila-Levy CM (2011) MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut. PLoS One 6: e18371.
17. Toté K, Van den Berghe D, Levecque S, Bénéré E, Maes L, et al. (2009) Evaluation of hydrogen peroxide-based disinfectants in a new resazurin microplate method for rapid efficacy testing of biocides. J Appl Microbiol 107: 606-615.
18. Macedo-Silva ST, de Oliveira Silva TL, Urbina JA, de Souza W, Rodrigues JC (2011) Antiproliferative, ultrastructural, and physiological effects of amiodarone on promastigote and amastigote forms of Leishmania amazonensis. Mol Biol Int 2011: 876021.
19. Souto-Padrón T, Campetella OE, Cazzulo JJ, de Souza W (1990) Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. J Cell Sci 96: 485-490.
20. Portes JA, Netto CD, Silva AJM, Costa PR, DaMatta RA, et al. (2012) A new type of terocarpanquinone that affects Toxoplasma gondii tachyzoites in vitro. Vet Parasitol 186: 261-269.
21. Koonin EV, Aravind L (2002) Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ 9: 394-404. (Pubitemid 34814619)
22. Mehta A, Shaha C (2004) Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity. J Biol Chem 279: 11798-11813. (Pubitemid 38401685)
23. Paris C, Loiseau PM, Bories C, Bréard J (2004) Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 48: 852-859. (Pubitemid 38280335)
24. Marinho FA, Gonçalves KC, Oliveira SS, Oliveira AC, Bellio M, et al. (2011) Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes. Mem Inst Oswaldo Cruz 106: 507-509.
25. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279.
26. Bortner CD, Oldenburg NB, Cidlowski JA (1995) The role of DNA fragmentation in apoptosis. Trends Cell Biol 5: 21-26.
27. Dutta A, Ghoshal A, Mandal D, Mondal NB, Banerjee S, et al. (2007) Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani. J Med Microbiol 56: 1196-1204. (Pubitemid 47477192)
28. Vannier-Santos MA, De Castro SL (2009) Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill. Curr Drug Targets 10: 246-260.
29. Verma NK, Singh G, Dey CS (2007) Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exp Parasitol 116: 1-13. (Pubitemid 46412310)
30. Wanderley JLM, Silva LHP, Deolindo P, Soong L, Borges VM, et al. (2009) Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of leishmaniasis. PLoS One 4: e5733.
31. Weingärtner A, Kemmer G, Müller FD, Zampieri RA, Santos MG, et al. (2012) Leishmania promastigotes lack phosphatidylserine but bind Annexin V upon permeabilization or miltefosine treatment. PLoS One 7: e42070.
32. Imbert L, Ramos RG, Libong D, Abreu S, Loiseau PM, et al. (2012) Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis. Anal Bioanal Chem 402: 1169-1182.
33. Wanderley JLM, Moreira MEC, Benjamin A, Bonomo AC, Barcinski MA (2006) Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. J Immunol 176: 1834-1839. (Pubitemid 43134328)
34. Smirlis D, Duszenko M, Jimenez-Ruiz AJ, Scoulica E, Bastien P, et al. (2010) Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death. Parasit Vectors 3: 107.
35. Smirlis D, Soteriadou K (2011) Trypanosomatid apoptosis: 'Apoptosis' without the canonical regulators. Virulence 2: 253-256.
36. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, et al. (2006) Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci USA 103: 13837-13842. (Pubitemid 44413994)
37. Foucher AL, Rachidi N, Gharbi S, Blisnick T, Bastin P, et al. (2013) Apoptotic marker expression in the absence of cell death in staurosporine- treated Leishmania donovani. Antimicrob Ag Chemother 57: 1252-1261.
38. Proto W, Coombs GH, Mottram JC (2013) Cell death in parasitic protozoa: regulated or incidental? Nat Rev Microbiol 11: 58-66.
39. Feinstein-Rotkopf Y, Arama E (2009) Can't live without them, can live with them: roles of caspases during vital cellular processes. Apoptosis 14: 980-995.
40. Constantinou C, Papas KA, Constantinou AI (2009) Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? Curr Cancer Drug Targets 9: 717-728.
41. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, et al. (2002) Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ 9: 53-64. (Pubitemid 34071993)
42. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, et al. (1996) Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci USA 93: 6008-6013. (Pubitemid 26190793)
43. El-Fadili AK, Zangger H, Desponds C, Gonzalez IJ, Zalila H, et al. (2010) Cathepsin B-like and cell death in the unicellular human pathogen Leishmania. Cell Death Dis 1: e71.
44. Rami A, Ferger D, Krieglstein J (1997) Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res 27: 93-97. (Pubitemid 27117101)
45. Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, et al. (2002) Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amasigotes. Infect Immun 70: 3727-3735. (Pubitemid 34666012)
46. Sereno D, Holzmuller P, Mangot I, Cuny G, Ouaissi A, et al. (2001) Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother 45: 2064-2069. (Pubitemid 32591699)
47. Singh G, Dey CS (2007) Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani. Acta Trop 103: 172-185. (Pubitemid 47301771)
48. Kumar P, Lodge R, Trudel N, Ouellet M, Ouellette M, et al. (2010) Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes. PLoS Negl Trop Dis 4: e642.
49. Jayanarayan KG, Dey CS (2005) Altered tubulin dynamics, localization and posttranslational modifications in sodium arsenite resistant Leishmania donovani in response to paclitaxel, trifluralin and a combination of both and induction of apoptosis-like cell death. Parasitology 131: 215-230. (Pubitemid 41191723)
50. Mollinedo F, Gajate C (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450. (Pubitemid 37247987)
51. Kidd JF, Pilkington MF, Schell MJ, Fogarty KE, Skepper JN, et al. (2002) Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem 277: 6504-6510. (Pubitemid 34968448)
52. Selvapandiyan A, Debrabant A, Duncan R, Muller J, Salotra P, et al. (2004) Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania. J Biol Chem 279: 25703-25710. (Pubitemid 38756834)
53. Sorimachi H, Ishiura S, Suzuki K (1997) Structure and physiological function of calpains. Biochem J 328: 721-732. (Pubitemid 28005767)
54. Hertz-Fowler C, Ersfeld K, Gull K (2001) CAP5.5, a life-cycle-regulated, cytoskeleton-associated protein is a member of a novel family of calpain-related proteins in Trypanosoma brucei. Mol Biochem Parasitol 116: 25-34. (Pubitemid 32706424)
55. Olego-Fernandez S, Vaughan S, Shaw MK, Gull K, Ginger ML (2009) Cell morphogenesis of Trypanosoma brucei requires the paralogous, differentially expressed calpain-related proteins CAP5.5 and CAP5.5V. Protist 160: 576-590.
56. Galetović A, Souza RT, Santos MR, Cordero EM, Bastos IM, et al. (2011) The repetitive cytoskeletal protein H49 of Trypanosoma cruzi is a calpain-like protein located at the flagellum attachment zone. PLoS One 6: e27634.